Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb 11;7(2):28.
doi: 10.3390/medsci7020028.

Identification of Prognostic and Predictive Osteosarcoma Biomarkers

Radoslav Zamborsky  1 , Milan Kokavec  2 , Stefan Harsanyi  3 , Lubos Danisovic  4
Affiliations
Review

Identification of Prognostic and Predictive Osteosarcoma Biomarkers

Radoslav Zamborsky et al. Med Sci (Basel). .

Abstract

Both adolescents and children suffer from osteosarcoma, localized in the metaphysis of the long bones. This is the most common primary high-grade bone tumor in this patient group. Early tumor detection is the key to ensuring effective treatment. Improved osteosarcoma outcomes in clinical trials have been contingent on biomarker discovery and an evolving understanding of molecules and their complex interactions. In this review, we present a short overview of biomarkers for osteosarcoma, and highlight advances in osteosarcoma-related biomarker research. Many studies show that several biomarkers undergo critical changes with osteosarcoma progression. Growing knowledge about osteosarcoma-related markers is expected to positively impact the development of therapeutics for osteosarcoma, and ultimately of clinical care. It has also become important to develop new biomarkers, which can identify vulnerable patients who should be treated with more intensive and aggressive therapy after diagnosis.

Keywords: biomarkers; chemotherapy; malignant bone tumors; osteosarcoma; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Boyer A.B., Richerand A., Farrell M. The lectures of Boyer upon diseases of the bones. [(accessed on 25 November 2018)]; Available online: https://archive.org/details/b21299304.
    1. Mirabello L., Troisi R.J., Savage S.A. Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009;115:1531–1543. doi: 10.1002/cncr.24121. - DOI - PMC - PubMed
    1. Meyers P.A., Gorlick R. Osteosarcoma. Pediatr. Clin. N. Am. 1997;44:973–989. doi: 10.1016/S0031-3955(05)70540-X. - DOI - PubMed
    1. Duchman K.R., Gao Y., Miller B.J. Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database. Cancer Epidemiol. 2015;39:593–599. doi: 10.1016/j.canep.2015.05.001. - DOI - PubMed
    1. Bielack S.S., Kempf-Bielack B., Delling G., Exner G.U., Flege S., Helmke K., Kotz R., Salzer-Kuntschik M., Werner M., Winkelmann W., et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J. Clin. Oncol. 2002;20:776–790. doi: 10.1200/JCO.2002.20.3.776. - DOI - PubMed

LinkOut - more resources